PLETAL Side Effects

6832200-5 | Anaemia, Cardiac Failure, Pneumonia, Pulmonary Oedema, Respiratory Tract Infection, Rib Fracture, Ventricular Fibrillation
on Jun 24, 2010 Male patient from JAPAN , 75 years of age, weighting 119.7 lb, was diagnosed with angina pectoris and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cardiac failure, pneumonia (What is pneumonia?), pulmonary oedema, respiratory tract infection, rib fracture, ventricular fibrillation. Pletal dosage: 100 Mg, Bid, Oral, 50 Mg, Bid Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), MUCODYNE DS (CARBOCISTEINE) (View Mucodyne Ds (carbocisteine) Review and Mucodyne Ds (carbocisteine) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ). Patient was hospitalized.

6831793-1 | Dizziness, Ear Haemorrhage, Urinary Retention, Visual Acuity Reduced
Patient was taking Pletal (View Usage). Patient had the following side effects: dizziness (What is dizziness?), ear haemorrhage, urinary retention, visual acuity reduced on Jun 22, 2010 from SPAIN Additional patient health information: Male patient , 54 years of age, was diagnosed with venous insufficiency, neuropathy peripheral and. Pletal dosage: 100 Mg, Oral. During the same period patient was treated with CLOPIDOGREL BISULFATE (75 Mg, Oral) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HIDROXIL B12 B6 B1 (HYDROXOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMI (Oral) (View Hidroxil B12 B6 B1 (hydroxocobalamin, Pyridoxine Hydrochloride, Thiami Review and Hidroxil B12 B6 B1 (hydroxocobalamin, Pyridoxine Hydrochloride, Thiami Label ), GABAPENTIN (Regimen 300 Mg;qd; Oral) (View Gabapentin Review and Gabapentin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SUTRIL (TORASEMIDE) (View Sutril (torasemide) Review and Sutril (torasemide) Label ).

6821761-8 | Interstitial Lung Disease
Adverse event was reported on Jun 24, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 50 Mg, Qd, Oral) was diagnosed with cerebral infarction, back pain (What is back pain?), hyperuricaemia and. Location: JAPAN , 81 years of age, weighting 337.3 lb, After Pletal was administered, patient had the following side effects: interstitial lung disease. During the same period patient was treated with TEGRETOL (200 Mg, Qd, Oral) (View Tegretol Review and Tegretol Label ), TICPILONE (TICLOPIDINE HYDROCHLORIDE) TABLET, 100 MG (100mg, Oral) (View Ticpilone (ticlopidine Hydrochloride) Tablet, 100 Mg Review and Ticpilone (ticlopidine Hydrochloride) Tablet, 100 Mg Label ), SALOBEL (ALLOPURINOL) TABLET, 100 MG (100mg, Oral) (View Salobel (allopurinol) Tablet, 100 Mg Review and Salobel (allopurinol) Tablet, 100 Mg Label ), SAWADOL L (ISOSORBIDE DINITRATE) (View Sawadol L (isosorbide Dinitrate) Review and Sawadol L (isosorbide Dinitrate) Label ), YODEL S (SENNA EXTRACT) (View Yodel-s (senna Extract) Review and Yodel-s (senna Extract) Label ), IRBETAN (IRBESARTAN) (View Irbetan (irbesartan) Review and Irbetan (irbesartan) Label ), PRAVATIN (PRAVASTATIN SODIUM) (View Pravatin (pravastatin Sodium) Review and Pravatin (pravastatin Sodium) Label ), ALTAT (ROXATIDINE ACETATE HYDROCHLORIDE) (View Altat (roxatidine Acetate Hydrochloride) Review and Altat (roxatidine Acetate Hydrochloride) Label ).

6821760-6 | Hepatic Neoplasm Malignant Recurrent
on Jun 23, 2010 Male patient from JAPAN , 76 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant recurrent. Pletal dosage: 50 Mg, Qd, Oral. During the same period patient was treated with ASPIRIN (100 Mg, Qd, Oral) (View Aspirin Review and Aspirin Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ).


6821755-2 | Gastric Ulcer Haemorrhage
on Jun 24, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). Patient had the following side effects: gastric ulcer haemorrhage. Pletal dosage: 50 Mg, Bid, Oral. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), CIBENOL (CIBENZOLINE SUCCINATE) (View Cibenol (cibenzoline Succinate) Review and Cibenol (cibenzoline Succinate) Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), GASMOTIN (MOSAPRIDE CITRATE) (View Gasmotin (mosapride Citrate) Review and Gasmotin (mosapride Citrate) Label ), NAUZELIN (DOMPERIDONE) (View Nauzelin (domperidone) Review and Nauzelin (domperidone) Label ), GOREL SAN (HERBAL EXTRACTS NOS) (View Gorel-san (herbal Extracts Nos) Review and Gorel-san (herbal Extracts Nos) Label ). Patient was hospitalized.

6821754-0 | Cerebellar Haemorrhage, Dizziness, Lacunar Infarction, Memory Impairment, Pneumonia
Patient was taking Pletal (View Usage). After Pletal was administered, patient had the following side effects: cerebellar haemorrhage, dizziness (What is dizziness?), lacunar infarction, memory impairment, pneumonia (What is pneumonia?) on Jun 22, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, weighting 125.7 lb, was diagnosed with platelet aggregation inhibition, cerebral infarction and. Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with ASPIRIN (100 Mg, Qd, Oral) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6818802-0 | Dyspnoea, Nail Discolouration, Oedema Peripheral, Pleural Effusion, Weight Decreased
Adverse event was reported on Jun 21, 2010 by a Female patient taking Pletal (View Usage) (Dosage: Oral) . Location: JAPAN , weighting 146.4 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, nail discolouration, oedema peripheral, pleural effusion, weight decreased. During the same period patient was treated with CALBLOCK (AZELNIDIPINE) (View Calblock (azelnidipine) Review and Calblock (azelnidipine) Label ), WARFARIN (WARFARIN POTASSIUM) (View Warfarin (warfarin Potassium) Review and Warfarin (warfarin Potassium) Label ), DIART (AZOSEMIDE) (View Diart (azosemide) Review and Diart (azosemide) Label ), DIOVAN (View Diovan Review and Diovan Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), TALION (BEPOTASTINE BESILATE) (View Talion (bepotastine Besilate) Review and Talion (bepotastine Besilate) Label ), ZONISAMIDE (View Zonisamide Review and Zonisamide Label ), MUCODYNE (CARBOCISTEINE) (View Mucodyne (carbocisteine) Review and Mucodyne (carbocisteine) Label ). Patient was hospitalized.

6818799-3 | Agranulocytosis, Blood Disorder, Thrombocytopenia
on Jun 18, 2010 Female patient from JAPAN , 77 years of age, was treated with Pletal (View Usage). Patient had the following side effects: agranulocytosis, blood disorder, thrombocytopenia. Pletal dosage: Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DIOVAN (View Diovan Review and Diovan Label ), METHYCOBAL (MECOBALAMIN) (View Methycobal (mecobalamin) Review and Methycobal (mecobalamin) Label ), KINEDAK (EPALRESTAT) (View Kinedak (epalrestat) Review and Kinedak (epalrestat) Label ).

6818798-1 | Chorea, Diabetic Complication, Hyperglycaemic Hyperosmolar Nonketotic Syndrome
on Jun 16, 2010 Male patient from JAPAN , 54 years of age, was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: chorea, diabetic complication, hyperglycaemic hyperosmolar nonketotic syndrome. Pletal dosage: 100 Mg, Bid Oral. Patient was hospitalized.

6817099-5 | Cardiac Failure Acute
Patient was taking Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure acute on Jun 18, 2010 from SWEDEN Additional patient health information: Male patient , 89 years of age, was diagnosed with intermittent claudication and. Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6817098-3 | Gastric Ulcer Haemorrhage, Shock Haemorrhagic
Adverse event was reported on Jun 15, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 100 Mg, Daily Dose) was diagnosed with arteriosclerosis obliterans and. Location: JAPAN , 59 years of age, Patient had the following side effects: gastric ulcer haemorrhage, shock haemorrhagic. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), GASTRIC COATING AGENT (GASTRIC COATING AGENT) (View Gastric Coating Agent (gastric Coating Agent) Review and Gastric Coating Agent (gastric Coating Agent) Label ), ANTIPYRETICS, ANALGESICS AND ANTI INFLAMMATORY AGENTS (View Antipyretics, Analgesics And Anti-inflammatory Agents Review and Antipyretics, Analgesics And Anti-inflammatory Agents Label ).

6817083-1 | Neutropenia
on Jun 15, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with renal failure chronic and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: neutropenia. Pletal dosage: 100 Mg, Qd Oral. During the same period patient was treated with PRAVASTATIN SODIUM (10 Mg, Qd, Oral) (View Pravastatin Sodium Review and Pravastatin Sodium Label ), LENDORMIN (BROTIZOLAM) (TABLET) (0.25 Mg, Qd, Oral) (View Lendormin (brotizolam) (tablet) Review and Lendormin (brotizolam) (tablet) Label ), FUTHAN (NAFAMOSTAT MESILATE) (150 Mg At Hemodialysis) (View Futhan (nafamostat Mesilate) Review and Futhan (nafamostat Mesilate) Label ).

6816466-3 | Acute Myocardial Infarction, Atrial Fibrillation, Cardiac Failure Congestive, Decreased Appetite, Pneumonia
on Jun 15, 2010 Male patient from JAPAN , 96 years of age, was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive, decreased appetite, pneumonia (What is pneumonia?). Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), PURSENNID (SENNOSIDE) TABLET (View Pursennid (sennoside) Tablet Review and Pursennid (sennoside) Tablet Label ).

6816465-1 | Respiratory Arrest
Patient was taking Pletal (View Usage). Patient had the following side effects: respiratory arrest on Jun 18, 2010 from JAPAN Additional patient health information: Female patient , 87 years of age, was diagnosed with arteriosclerosis obliterans and. Pletal dosage: 50 Mg, Qd Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), B BLOCKING AGENTS (View B-blocking Agents Review and B-blocking Agents Label ), ITOROL (ISOSORBIDE MONONITRATE) TABLET (View Itorol (isosorbide Mononitrate) Tablet Review and Itorol (isosorbide Mononitrate) Tablet Label ), ALFAROL(ALFACALCIDOL) (View Alfarol(alfacalcidol) Review and Alfarol(alfacalcidol) Label ), BONALON (ALENDRONATE SODIUM HYDRATE) TABLET (View Bonalon (alendronate Sodium Hydrate) Tablet Review and Bonalon (alendronate Sodium Hydrate) Tablet Label ).

6816464-X | Hyperkalaemia
Adverse event was reported on Jun 22, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 50 Mg, Bid, Oral; 100 Mg, Bid, Oral) was diagnosed with cerebral infarction and. Location: JAPAN , 77 years of age, weighting 128.5 lb, After Pletal was administered, patient had the following side effects: hyperkalaemia. During the same period patient was treated with AMLODIN (AMLODIPINE BESILATE) TABLET (View Amlodin (amlodipine Besilate) Tablet Review and Amlodin (amlodipine Besilate) Tablet Label ), PLAVIX (View Plavix Review and Plavix Label ), PREMINENT (LOSARTAN POTASSIUM_HYDROCHLOROTHIAZIDE) TABLET (View Preminent (losartan Potassium_hydrochlorothiazide) Tablet Review and Preminent (losartan Potassium_hydrochlorothiazide) Tablet Label ), DEPAS (ETIZOLAM) TABLET (View Depas (etizolam) Tablet Review and Depas (etizolam) Tablet Label ), MAGLAX (MAGNESIUM OXIDE) TABLET (View Maglax (magnesium Oxide) Tablet Review and Maglax (magnesium Oxide) Tablet Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

6816463-8 | Acute Myocardial Infarction, Cerebral Infarction, Kidney Fibrosis, Renal Disorder, Renal Tubular Atrophy, Unevaluable Event
on Jun 17, 2010 Male patient from JAPAN , 59 years of age, was diagnosed with cerebral infarction, renal transplant and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, cerebral infarction, kidney fibrosis, renal disorder, renal tubular atrophy, unevaluable event. Pletal dosage: . During the same period patient was treated with PROGRAF (2 Mg, Bid Oral; 1.5 Mg, Bid, Oral) (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PARIET (RABEPRAZOLE SODIUM) TABLET (View Pariet (rabeprazole Sodium) Tablet Review and Pariet (rabeprazole Sodium) Tablet Label ), MUCOSTA (REBAMIPIDE) TABLET (View Mucosta (rebamipide) Tablet Review and Mucosta (rebamipide) Tablet Label ), LASIX (View Lasix Review and Lasix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6811800-2 | Chest Pain, Hyperhidrosis, Malaise, Palpitations
on Jun 15, 2010 Male patient from UNITED KINGDOM , 70 years of age, weighting 201.1 lb, was treated with Pletal (View Usage). Patient had the following side effects: chest pain (What is chest pain?), hyperhidrosis, malaise, palpitations. Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with ALFUZOSIN (ALFUZOSIN) (View Alfuzosin (alfuzosin) Review and Alfuzosin (alfuzosin) Label ), CODEINE SUL TAB (View Codeine Sul Tab Review and Codeine Sul Tab Label ), GTN (GLYCERYL TRINITRATE) (View Gtn (glyceryl Trinitrate) Review and Gtn (glyceryl Trinitrate) Label ), ISOTARD XL (ISOSORBIDE MONONITRATE) (View Isotard Xl (isosorbide Mononitrate) Review and Isotard Xl (isosorbide Mononitrate) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), NICORANDIL (NICORANDIL) (View Nicorandil (nicorandil) Review and Nicorandil (nicorandil) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6811799-9 | Renal Failure
Patient was taking Pletal (View Usage). After Pletal was administered, patient had the following side effects: renal failure on Jun 14, 2010 from SPAIN Additional patient health information: Male patient , 78 years of age, was diagnosed with intermittent claudication and. Pletal dosage: .

6811508-3 | Chest Discomfort, Circulatory Collapse, Fall, Loss Of Consciousness, Syncope, Ventricular Tachycardia
Adverse event was reported on Jun 11, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 100 Mg, Bid, Oral) was diagnosed with hypoaesthesia and. Location: JAPAN , 85 years of age, weighting 97.00 lb, Patient experienced the following unwanted or unexpected effects: chest discomfort, circulatory collapse, fall (What is fall?), loss of consciousness, syncope, ventricular tachycardia. During the same period patient was treated with MEXITIL (View Mexitil Review and Mexitil Label ), TANATRIL (MIDAPRIL HYDROCHLORIDE) (View Tanatril (midapril Hydrochloride) Review and Tanatril (midapril Hydrochloride) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PURSENNID (SENNOSIDE) (View Pursennid (sennoside) Review and Pursennid (sennoside) Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

6801101-0 | Diarrhoea, Lacunar Infarction, Loss Of Consciousness, Pruritus, Tinnitus, Transient Ischaemic Attack
on Jun 15, 2010 Male patient from JAPAN , 75 years of age, weighting 150.8 lb, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). Patient had the following side effects: diarrhoea, lacunar infarction, loss of consciousness, pruritus, tinnitus (What is tinnitus?), transient ischaemic attack. Pletal dosage: 50 Mg, Qd, Oral. During the same period patient was treated with DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), OMEPRAL (OMEPRAZOLE) TABLET (View Omepral (omeprazole) Tablet Review and Omepral (omeprazole) Tablet Label ), AMLODIN OD (AMLODIPINE BESILATE) TABLET (View Amlodin Od (amlodipine Besilate) Tablet Review and Amlodin Od (amlodipine Besilate) Tablet Label ), GASLON N (IRSOGLADINE MALEATE) TABLET (View Gaslon N (irsogladine Maleate) Tablet Review and Gaslon N (irsogladine Maleate) Tablet Label ).

6796348-6 | Gastric Ulcer Haemorrhage, Metastases To Liver
on Jun 15, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with arteriosclerosis and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: gastric ulcer haemorrhage, metastases to liver. Pletal dosage: 50mg, Bid. Patient was hospitalized.

6796347-4 | Cardiac Failure Acute
Patient was taking Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure acute on Jun 10, 2010 from SWEDEN Additional patient health information: Male patient , 89 years of age, was diagnosed with intermittent claudication and. Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6785152-0 | Haemorrhagic Cerebral Infarction
Adverse event was reported on Jun 10, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 100 Mg, Bid, Oral) was diagnosed with cerebral infarction and. Location: JAPAN , 59 years of age, Patient had the following side effects: haemorrhagic cerebral infarction. During the same period patient was treated with CATACLOT (OZAGREL SODIUM) INJECTION (View Cataclot (ozagrel Sodium) Injection Review and Cataclot (ozagrel Sodium) Injection Label ).

6785151-9 | Hyperkalaemia
on Jun 09, 2010 Male patient from JAPAN , 77 years of age, was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: hyperkalaemia. Pletal dosage: 50 Mg, Bid, Oral. During the same period patient was treated with AMLODIN (AMLODIPINE BESILATE) TABLET (View Amlodin (amlodipine Besilate) Tablet Review and Amlodin (amlodipine Besilate) Tablet Label ), PLAVIX (View Plavix Review and Plavix Label ), PREMINENT (LOSARTAN POTASSIUM_ HYDROCHLOROTHIAZIDE) TABLET (View Preminent (losartan Potassium_ Hydrochlorothiazide) Tablet Review and Preminent (losartan Potassium_ Hydrochlorothiazide) Tablet Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), MAGLAX (MAGNESIUM OXIDE) (View Maglax (magnesium Oxide) Review and Maglax (magnesium Oxide) Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

6784313-4 | Respiratory Arrest
on Jun 07, 2010 Female patient from JAPAN , 87 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory arrest. Pletal dosage: 50 Mg, Qd, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), B BLOCKING AGENTS (View B-blocking Agents Review and B-blocking Agents Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), BONALON (ALENDRONATE SODIUM HYDRATE) (View Bonalon (alendronate Sodium Hydrate) Review and Bonalon (alendronate Sodium Hydrate) Label ).

6784310-9 | Blood Pressure Decreased, Cardiac Failure, Pulmonary Oedema, Respiratory Failure, Respiratory Tract Infection, Rib Fracture, Ventricular Fibrillation
Patient was taking Pletal (View Usage). Patient had the following side effects: blood pressure decreased, cardiac failure, pulmonary oedema, respiratory failure, respiratory tract infection, rib fracture, ventricular fibrillation on Jun 08, 2010 from JAPAN Additional patient health information: Male patient , 75 years of age, weighting 119.7 lb, was diagnosed with angina pectoris and. Pletal dosage: 100 Bid, Oral, 50 Mg Bid, Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), MUCODYNE DS (CARBOCISTEINE) (View Mucodyne Ds (carbocisteine) Review and Mucodyne Ds (carbocisteine) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ). Patient was hospitalized.

6773643-8 | Angina Unstable, Condition Aggravated, Coronary Artery Stenosis, Electrocardiogram St Segment Elevation, Leriche Syndrome, Liver Disorder, Pulmonary Fibrosis, Thrombosis In Device
Adverse event was reported on Jun 04, 2010 by a Male patient taking Pletal (View Usage) (Dosage: Oral) . Location: JAPAN , 84 years of age, After Pletal was administered, patient had the following side effects: angina unstable, condition aggravated, coronary artery stenosis, electrocardiogram st segment elevation, leriche syndrome, liver disorder, pulmonary fibrosis (What is pulmonary fibrosis?), thrombosis in device.

6771523-5 | Cerebellar Haemorrhage
on Jun 03, 2010 Male patient from JAPAN , 79 years of age, was diagnosed with lacunar infarction and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: cerebellar haemorrhage. Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with ASPIRIN (100 Mg, Qd Oral) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6771522-3 | Blood Creatinine Increased
on Jun 01, 2010 Male patient from GERMANY , 80 years of age, was treated with Pletal (View Usage). Patient had the following side effects: blood creatinine increased. Pletal dosage: .

6764030-7 | Myocardial Infarction
Patient was taking Pletal (View Usage). After Pletal was administered, patient had the following side effects: myocardial infarction on May 27, 2010 from JAPAN Additional patient health information: Female patient , 83 years of age, was diagnosed with arteriosclerosis obliterans and. Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with EPADEL (ETHYL ICOSAPENTATE) CAPSULE (900 Mg, Bid Oral) (View Epadel (ethyl Icosapentate) Capsule Review and Epadel (ethyl Icosapentate) Capsule Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), NOVOLIN N (INSULIN HUMAN(GENETICAL RECOMBINATION)) INJECTION (View Novolin N (insulin Human(genetical Recombination)) Injection Review and Novolin N (insulin Human(genetical Recombination)) Injection Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), CONIEL (BENIDIPINE HYDROCHLORIDE) TABLET (View Coniel (benidipine Hydrochloride) Tablet Review and Coniel (benidipine Hydrochloride) Tablet Label ), VESICARE (SOLIFENACIN SUCCINATE) TABLET (View Vesicare (solifenacin Succinate) Tablet Review and Vesicare (solifenacin Succinate) Tablet Label ). Patient was hospitalized.

6761374-X | Shock
Adverse event was reported on May 26, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 100 Mg, Qpm, Oral) was diagnosed with carotid artery stenosis and. Location: JAPAN , 87 years of age, Patient experienced the following unwanted or unexpected effects: shock. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), CILNIDIPINE (View Cilnidipine Review and Cilnidipine Label ).

6761373-8 | Blood Potassium Increased
on May 24, 2010 Male patient from JAPAN , 77 years of age, was treated with Pletal (View Usage). Patient had the following side effects: blood potassium increased. Pletal dosage: Oral. During the same period patient was treated with LACTEC (LATATED RINGERS) (View Lactec (latated Ringers) Review and Lactec (latated Ringers) Label ), DEXTRAN 40 (View Dextran 40 Review and Dextran 40 Label ).

6760289-0 | Akinesia, Cardiac Failure, Cardiogenic Shock
on May 25, 2010 Male patient from GERMANY , 64 years of age, was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: akinesia, cardiac failure, cardiogenic shock. Pletal dosage: 100 Mg, Oral. During the same period patient was treated with LORZAAR (LOSARTAN POTASSIUM) (View Lorzaar (losartan Potassium) Review and Lorzaar (losartan Potassium) Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), EZETROL GFR (EZETIMIBE) (View Ezetrol Gfr (ezetimibe) Review and Ezetrol Gfr (ezetimibe) Label ), AMARYL SWE (GLIMEPIRIDE) (View Amaryl Swe (glimepiride) Review and Amaryl Swe (glimepiride) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6760288-9 | Haemorrhage, Iron Deficiency, Microcytic Anaemia
Patient was taking Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, iron deficiency, microcytic anaemia on May 25, 2010 from GERMANY Additional patient health information: Male patient , 70 years of age, . Pletal dosage: 100 Mg, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), NOVODIGAL (BISOPROLOL) (View Novodigal (bisoprolol) Review and Novodigal (bisoprolol) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6759904-7 | Anaemia, Cardiac Failure, Depressed Level Of Consciousness, Dysstasia, Faecal Incontinence, Heart Rate Increased
Adverse event was reported on May 25, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 100 Mg, Bid Oral) was diagnosed with arterial occlusive disease and. Location: JAPAN , 84 years of age, Patient had the following side effects: anaemia, cardiac failure, depressed level of consciousness, dysstasia, faecal incontinence, heart rate increased. During the same period patient was treated with CRESTOR (ROSUVASTATIN) TABLET (View Crestor (rosuvastatin) Tablet Review and Crestor (rosuvastatin) Tablet Label ), HARNAL D (TAMSULOSIN HYDROCHLORIDE) TABLET (View Harnal D (tamsulosin Hydrochloride) Tablet Review and Harnal D (tamsulosin Hydrochloride) Tablet Label ), PROSTAL (CHLORMADINONE ACETATE) TABLET (View Prostal (chlormadinone Acetate) Tablet Review and Prostal (chlormadinone Acetate) Tablet Label ), CONIEL (BENIDIPINE HYDROCHLORIDE) TABLET (View Coniel (benidipine Hydrochloride) Tablet Review and Coniel (benidipine Hydrochloride) Tablet Label ), ARICEPT D (DONEPEZIL HYDROCHLORIDE) TABLET (View Aricept D (donepezil Hydrochloride) Tablet Review and Aricept D (donepezil Hydrochloride) Tablet Label ), STAYBLA (IMIDAFENACIN) TABLET (View Staybla (imidafenacin) Tablet Review and Staybla (imidafenacin) Tablet Label ), ZETIA (EZETIMIBE) TABLET (View Zetia (ezetimibe) Tablet Review and Zetia (ezetimibe) Tablet Label ).

6755571-7 | Anaemia, Pleural Effusion, Renal Failure Acute
on May 19, 2010 Female patient from JAPAN , 93 years of age, was diagnosed with cardiac pacemaker insertion and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: anaemia, pleural effusion, renal failure acute. Pletal dosage: 100 Mg, Bid Oral. During the same period patient was treated with CEFDINIR (100 Mg, Bid Oral) (View Cefdinir Review and Cefdinir Label ), CEFAZOLIN SODIUM (CEFAZOLIN SODIUM) INJECTION (View Cefazolin Sodium (cefazolin Sodium) Injection Review and Cefazolin Sodium (cefazolin Sodium) Injection Label ), ARICEPT D (DONEPEZIL HYDROCHLORIDE) TABLET (View Aricept D (donepezil Hydrochloride) Tablet Review and Aricept D (donepezil Hydrochloride) Tablet Label ), LASIX (View Lasix Review and Lasix Label ), BLOPRESS (CANDESARTAN CILEXETIL) TABLET (View Blopress (candesartan Cilexetil) Tablet Review and Blopress (candesartan Cilexetil) Tablet Label ). Patient was hospitalized.

6750512-0 | Cardiogenic Shock, Decreased Appetite, Dehydration, Diarrhoea, Electrolyte Imbalance, No Therapeutic Response, Renal Failure, Respiratory Disorder, Ventricular Tachycardia
on May 19, 2010 Male patient from JAPAN , 61 years of age, weighting 143.3 lb, was diagnosed with cerebral infarction and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, decreased appetite, dehydration, diarrhoea, electrolyte imbalance, no therapeutic response, renal failure, respiratory disorder, ventricular tachycardia. Pletal dosage: 100 Mg, Bid; Oral. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ZYLORIC (ALLOPURINOL) TABLET, 100 MG (View Zyloric (allopurinol) Tablet, 100 Mg Review and Zyloric (allopurinol) Tablet, 100 Mg Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), BAYASPIRIN (ACETYLSALICYLIC ACID) TABLET, 100 MG (View Bayaspirin (acetylsalicylic Acid) Tablet, 100 Mg Review and Bayaspirin (acetylsalicylic Acid) Tablet, 100 Mg Label ), OMEPRAL (OMEPRAZOLE) TABLET, 10 MG (View Omepral (omeprazole) Tablet, 10 Mg Review and Omepral (omeprazole) Tablet, 10 Mg Label ), WARFARIN (WARFARIN POTASSIUM) TABLET, 1 MG (View Warfarin (warfarin Potassium) Tablet, 1 Mg Review and Warfarin (warfarin Potassium) Tablet, 1 Mg Label ). Patient was hospitalized.

6743559-1 | Dizziness, Shock
Patient was taking Pletal (View Usage). Patient had the following side effects: dizziness (What is dizziness?), shock on May 18, 2010 from JAPAN Additional patient health information: Male patient , 87 years of age, . Pletal dosage: 100 Mg Qdm. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), CILNIDIPINE (CILNIDIPINE) TABLET, 10MG (View Cilnidipine (cilnidipine) Tablet, 10mg Review and Cilnidipine (cilnidipine) Tablet, 10mg Label ).

6740709-8 | Cardiac Failure, Depressed Level Of Consciousness, Dysstasia, Face Oedema, Faecal Incontinence, Heart Rate Increased, Oedema Peripheral
Adverse event was reported on May 14, 2010 by a Male patient taking Pletal (View Usage) (Dosage: 100 Mg,bid, Oral) was diagnosed with arterial occlusive disease and. Location: JAPAN , 84 years of age, weighting 111.3 lb, After Pletal was administered, patient had the following side effects: cardiac failure, depressed level of consciousness, dysstasia, face oedema, faecal incontinence, heart rate increased, oedema peripheral. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), CHLORMADINONE ACETATE TAB (View Chlormadinone Acetate Tab Review and Chlormadinone Acetate Tab Label ), CONIEL (BENIDIPINE HYDROCHLORIDE) (View Coniel (benidipine Hydrochloride) Review and Coniel (benidipine Hydrochloride) Label ), ARICEPT (View Aricept Review and Aricept Label ), STAYBLA (MIDAFENACIN) (View Staybla (midafenacin) Review and Staybla (midafenacin) Label ), ZETIA (View Zetia Review and Zetia Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ).

6737642-4 | Left Ventricular Failure, Mitral Valve Incompetence, Sinus Tachycardia
on May 10, 2010 Male patient from SPAIN , 54 years of age, was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: left ventricular failure, mitral valve incompetence, sinus tachycardia. Pletal dosage: Oral. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), MICARDIS (View Micardis Review and Micardis Label ), LORMETAZEPAM (LORMETAZEPAM) (View Lormetazepam (lormetazepam) Review and Lormetazepam (lormetazepam) Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6735502-6 | Anaemia, Pleural Effusion, Renal Failure Acute
on May 18, 2010 Female patient from JAPAN , 93 years of age, was treated with Pletal (View Usage). Patient had the following side effects: anaemia, pleural effusion, renal failure acute. Pletal dosage: 100 Mg, Bid. During the same period patient was treated with CERFAZOLIN (CERFAZOLIN SODIUM) (View Cerfazolin (cerfazolin Sodium) Review and Cerfazolin (cerfazolin Sodium) Label ), CERFZON (CERDINIR) (View Cerfzon (cerdinir) Review and Cerfzon (cerdinir) Label ). Patient was hospitalized.

6732779-8 | Liver Disorder
Patient was taking Pletal (View Usage). After Pletal was administered, patient had the following side effects: liver disorder on May 07, 2010 from JAPAN Additional patient health information: Female patient , 61 years of age, . Pletal dosage: Oral. During the same period patient was treated with TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6732740-3 | Anaemia, Pleural Effusion, Renal Failure Acute
Adverse event was reported on May 06, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 100 Mg Bid, Oral) . Location: JAPAN , 93 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, pleural effusion, renal failure acute. During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), CEFZON (CEFDINIR) (View Cefzon (cefdinir) Review and Cefzon (cefdinir) Label ). Patient was hospitalized.

6731042-9 | Tumour Haemorrhage
on May 04, 2010 Male patient from JAPAN , 82 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). Patient had the following side effects: tumour haemorrhage. Pletal dosage: 100 Mg, Qd, Oral; 100 Mg, Qd; Oral. During the same period patient was treated with WARFARIN SODIUM (1.5 Mg,qd, Oral) (View Warfarin Sodium Review and Warfarin Sodium Label ), LASIX (View Lasix Review and Lasix Label ), MICARDIS (View Micardis Review and Micardis Label ), VERAPAMIL HYDROCHLORIDE (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6719695-2 | Abdominal Pain, Anaemia, Haematoma, Nausea, Pneumonia Aspiration
on Apr 26, 2010 Female patient from JAPAN , 77 years of age, was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, haematoma, nausea (What is nausea?), pneumonia aspiration. Pletal dosage: Oral. During the same period patient was treated with CIMETIDINE (View Cimetidine Review and Cimetidine Label ).

6713575-4 | Atrial Flutter, Loss Of Consciousness, Sick Sinus Syndrome
Patient was taking Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: atrial flutter, loss of consciousness, sick sinus syndrome on Apr 22, 2010 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 143.3 lb, was diagnosed with arteriosclerosis obliterans and. Pletal dosage: 50 Mg, Bid Oral; 100 Mg, Bid Oral. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), KALIMATE (CALCIUM POLYSTYRENE SULFONATE) (View Kalimate (calcium Polystyrene Sulfonate) Review and Kalimate (calcium Polystyrene Sulfonate) Label ), MERISLON (BETAHISTINE HYDROCHLORIDE) TABLET (View Merislon (betahistine Hydrochloride) Tablet Review and Merislon (betahistine Hydrochloride) Tablet Label ). Patient was hospitalized.

6709136-3 | Anaemia, Renal Failure
Adverse event was reported on Apr 22, 2010 by a Female patient taking Pletal (View Usage) (Dosage: 100 Mg, Bid Oral) . Location: JAPAN , 93 years of age, Patient had the following side effects: anaemia, renal failure. During the same period patient was treated with CEFAZOLIN SODIUM (CEFAZOLIN SODIUM) INJECTION (View Cefazolin Sodium (cefazolin Sodium) Injection Review and Cefazolin Sodium (cefazolin Sodium) Injection Label ), CEFZON (CEFDINIR) CAPSULE (View Cefzon (cefdinir) Capsule Review and Cefzon (cefdinir) Capsule Label ). Patient was hospitalized.

6701219-7 | Gastric Ulcer Haemorrhage, Haematemesis, Metastases To Liver
on Apr 20, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Pletal (View Usage). After Pletal was administered, patient had the following side effects: gastric ulcer haemorrhage, haematemesis, metastases to liver. Pletal dosage: 50 Mg, Bid, Oral. During the same period patient was treated with AGENTS FOR HYPERLIPIDEMIAS (View Agents For Hyperlipidemias Review and Agents For Hyperlipidemias Label ), CIBENOL (CIBENZOLINE SUCCINATE) (View Cibenol (cibenzoline Succinate) Review and Cibenol (cibenzoline Succinate) Label ). Patient was hospitalized.

6699484-8 | Atrial Fibrillation, Cerebrovascular Accident, Contusion, Fall, Hemiparesis, Hemiplegia, Pneumonia Aspiration
on Apr 12, 2010 Male patient from GERMANY , 85 years of age, was diagnosed with peripheral arterial occlusive disease and was treated with Pletal (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cerebrovascular accident, contusion, fall (What is fall?), hemiparesis, hemiplegia, pneumonia aspiration. Pletal dosage: 100 Mg, Qd, Oral. During the same period patient was treated with XIPAMIDE (XIPAMIDE) (View Xipamide (xipamide) Review and Xipamide (xipamide) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), DIOVANE (VALSARTAN) (View Diovane (valsartan) Review and Diovane (valsartan) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), PHENPROCOUMON (PHENPROCOUMON) (View Phenprocoumon (phenprocoumon) Review and Phenprocoumon (phenprocoumon) Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

6696417-5 | Acalculia, Agnosia, Brain Compression, Brain Oedema, Cerebral Hyperperfusion Syndrome, Cerebral Infarction, Cerebral Ischaemia, Dyslalia, Headache
Patient was taking Pletal (View Usage). Patient had the following side effects: acalculia, agnosia, brain compression, brain oedema, cerebral hyperperfusion syndrome, cerebral infarction, cerebral ischaemia, dyslalia, headache (What is headache?) on Apr 20, 2010 from JAPAN Additional patient health information: Male patient , 35 years of age, weighting 112.4 lb, was diagnosed with moyamoya disease and. Pletal dosage: 100 Mg, Bid, Oral. During the same period patient was treated with TAKEPRON (LANSOPRAZOLE) TABLET (View Takepron (lansoprazole) Tablet Review and Takepron (lansoprazole) Tablet Label ), ALEVIATIN (PHENYTOIN) INJECTION (View Aleviatin (phenytoin) Injection Review and Aleviatin (phenytoin) Injection Label ), NORVASC (View Norvasc Review and Norvasc Label ), BLOPRESS (CANDESARTAN CILEXETIL) TABLET (View Blopress (candesartan Cilexetil) Tablet Review and Blopress (candesartan Cilexetil) Tablet Label ), RADICUT (EDARAVONE) INJECTION (View Radicut (edaravone) Injection Review and Radicut (edaravone) Injection Label ).